Skip to main content

Featured

Tariff Costs Put New Pressure on U.S. Corporate Profits

Rising tariff expenses are beginning to weigh heavily on U.S. companies, prompting executives across multiple industries to warn that profit margins may tighten in the months ahead. Many firms had initially suggested they could manage the added costs through efficiency improvements or selective price increases, but that confidence is fading as import-related expenses continue to climb. Companies that rely on global supply chains are feeling the strain most acutely. Higher costs on imported materials and components are forcing difficult decisions: pass the increases on to consumers, risking weaker demand, or absorb the costs internally, which directly erodes profitability. For many businesses, neither option is attractive. Consumer-facing brands are finding it especially challenging to raise prices further, as shoppers show growing sensitivity to even modest increases. This resistance limits the ability of firms to offset tariff-driven expenses, creating a squeeze that is beginning t...

article

Senate to Decide Fate of Funding Bill as Shutdown Deadline Looms


In a dramatic turn of events, the U.S. House of Representatives approved a crucial funding bill just hours before the midnight deadline, sending it to the Senate for immediate consideration. The bill, which passed with a vote of 366-34, aims to temporarily fund federal operations and provide disaster aid, but notably excludes an increase in the debt ceiling as demanded by President-elect Donald Trump.

House Speaker Mike Johnson emphasized the importance of avoiding a government shutdown, especially during the holiday season, while acknowledging the challenges posed by Trump's last-minute demands. The bill now faces a critical test in the Senate, where its passage is expected but not guaranteed.

As the clock ticks down, all eyes are on the Senate to see if they can act swiftly enough to prevent a shutdown that would disrupt federal services and impact millions of Americans.




Comments